Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection (Q53100754)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 January 2011

Language	Label	Description	Also known as
English	Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection	scientific article published on 30 January 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Salvatore Petta

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Giuseppe Pizzolanti

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Donatella Ferraro

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Calogero Cammà

2

object named as

Calogero Cammà

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Carla Guarnotta

11

object named as

Carla Guarnotta

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Vito Di Marco

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Beatrice Belmonte

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Rosa Di Stefano

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Giovanna Venezia

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

30 January 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Liver International

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

507-515

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382161%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Viral and host causes of fatty liver in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Serum adiponectin in chronic hepatitis C and B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Insulin resistance in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Insulin resistance is not associated with histologic severity in nondiabetic, noncirrhotic patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Clinical significance of the insulin resistance index as assessed by homeostasis model assessment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Factors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic Hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02453.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53100754&oldid=1744659995"